Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	NOD-like receptor signaling pathway	7/181	2.8649990086944273e-10	2.091449276346932e-08	105.85823754789271	-313.9653002169225	AIM2;CASP1;IL1B;MEFV;NLRP1;PYCARD;TNF
KEGG_2021_Human	Pertussis	5/76	1.5675128124076017e-08	5.721421765287747e-07	112.63380281690141	-288.85723035226965	CASP1;IL1A;IL1B;PYCARD;TNF
KEGG_2021_Human	Yersinia infection	5/137	3.070399768694536e-07	7.471306103823371e-06	60.121212121212125	-177.50304940933535	CASP1;IL1B;MEFV;PYCARD;TNF
KEGG_2021_Human	Legionellosis	4/57	4.533460591014752e-07	8.273565578601922e-06	100.81761006289308	-216.95395722754864	CASP1;IL1B;PYCARD;TNF
KEGG_2021_Human	Cytosolic DNA-sensing pathway	4/63	6.811887802918996e-07	8.287796826884779e-06	90.49717514124293	-200.30830604753126	AIM2;CASP1;IL1B;PYCARD
KEGG_2021_Human	Necroptosis	5/159	6.457403055921121e-07	8.287796826884779e-06	51.38961038961039	-155.93286055355003	CASP1;IL1A;IL1B;PYCARD;TNF
KEGG_2021_Human	Influenza A	5/172	9.546833775920581e-07	9.955983794888607e-06	47.31137724550898	-145.44295329077605	CASP1;IL1A;IL1B;PYCARD;TNF
KEGG_2021_Human	C-type lectin receptor signaling pathway	4/104	5.130876847568527e-06	4.681925123406281e-05	53.12	-132.3420645012429	CASP1;IL1B;PYCARD;TNF
KEGG_2021_Human	Type I diabetes mellitus	3/43	1.6429423914376138e-05	0.0001199347945749458	86.01428571428572	-141.158089869663	IL1A;IL1B;TNF
KEGG_2021_Human	Graft-versus-host disease	3/42	1.5293149491516165e-05	0.0001199347945749458	88.23076923076923	-143.80928698800247	IL1A;IL1B;TNF
KEGG_2021_Human	Inflammatory bowel disease	3/65	5.7322256772471596e-05	0.0003804113403991297	55.34101382488479	-100.98537671170521	IL1A;IL1B;TNF
KEGG_2021_Human	Pathogenic Escherichia coli infection	4/197	6.421891077355903e-05	0.00039066504053915076	27.202072538860104	-74.37625984844887	CASP1;IL1B;PYCARD;TNF
KEGG_2021_Human	Lipid and atherosclerosis	4/215	9.035438443106581e-05	0.0004966468805816132	24.824644549763033	-68.34725873383007	CASP1;IL1B;PYCARD;TNF
KEGG_2021_Human	Leishmaniasis	3/77	9.524734696085732e-05	0.0004966468805816132	46.2972972972973	-87.57744084010389	IL1A;IL1B;TNF
KEGG_2021_Human	Rheumatoid arthritis	3/93	0.00016720908178540931	0.0007180154688432283	37.99047619047619	-74.4091590745228	IL1A;IL1B;TNF
KEGG_2021_Human	Salmonella infection	4/249	0.00015985480003693624	0.0007180154688432283	21.287074829931974	-59.07439560833883	CASP1;IL1B;PYCARD;TNF
KEGG_2021_Human	Shigellosis	4/246	0.00015252097444894315	0.0007180154688432283	21.55922865013774	-59.801482853342776	CASP1;IL1B;PYCARD;TNF
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	3/100	0.00020740615092509237	0.0007968762640806181	35.2179675994109	-69.8003308229761	IL1A;IL1B;TNF
KEGG_2021_Human	Hematopoietic cell lineage	3/99	0.00020131554786600544	0.0007968762640806181	35.589285714285715	-70.42440314178907	IL1A;IL1B;TNF
KEGG_2021_Human	Osteoclast differentiation	3/127	0.0004201187826005964	0.0015334335564921768	27.456221198156683	-56.21805005538481	IL1A;IL1B;TNF
KEGG_2021_Human	Fluid shear stress and atherosclerosis	3/139	0.0005476317685268026	0.0019036723382122186	24.99579831932773	-51.672386684351224	IL1A;IL1B;TNF
KEGG_2021_Human	Non-alcoholic fatty liver disease	3/155	0.0007531180482518497	0.002498982614653865	22.31954887218045	-46.57552582678881	IL1A;IL1B;TNF
KEGG_2021_Human	African trypanosomiasis	2/37	0.0008976760152685225	0.002849145613678354	57.378571428571426	-64.24352876962546	IL1B;TNF
KEGG_2021_Human	Tuberculosis	3/180	0.0011634285381276748	0.0035387618034716777	19.106537530266344	-40.222430877266724	IL1A;IL1B;TNF
KEGG_2021_Human	Malaria	2/50	0.0016370061401984127	0.004780057929379365	41.770833333333336	-50.1560330081587	IL1B;TNF
KEGG_2021_Human	Coronavirus disease	3/232	0.0024164136009215383	0.0067845458795104735	14.670617592014972	-30.966105875434415	CASP1;IL1B;TNF
KEGG_2021_Human	Prion disease	3/273	0.0038397781028777236	0.010381622278150883	12.377777777777778	-25.926933584065353	IL1A;IL1B;TNF
KEGG_2021_Human	Cytokine-cytokine receptor interaction	3/295	0.004778958454651453	0.012029791972053658	11.412915851272016	-23.74866982495136	IL1A;IL1B;TNF
KEGG_2021_Human	MAPK signaling pathway	3/294	0.0047334851717591615	0.012029791972053658	11.45360824742268	-23.841254126382374	IL1A;IL1B;TNF
KEGG_2021_Human	IL-17 signaling pathway	2/94	0.005673660825135872	0.013805908007830622	21.67391304347826	-28.742216935482162	IL1B;TNF
KEGG_2021_Human	Amoebiasis	2/102	0.006650847322673755	0.014828445831062895	19.92	-26.61700675496218	IL1B;TNF
KEGG_2021_Human	NF-kappa B signaling pathway	2/104	0.006906399428166279	0.014828445831062895	19.524509803921568	-26.130280011490946	IL1B;TNF
KEGG_2021_Human	Toll-like receptor signaling pathway	2/104	0.006906399428166279	0.014828445831062895	19.524509803921568	-26.130280011490946	IL1B;TNF
KEGG_2021_Human	Chagas disease	2/102	0.006650847322673755	0.014828445831062895	19.92	-26.61700675496218	IL1B;TNF
KEGG_2021_Human	TNF signaling pathway	2/112	0.007973056255711614	0.01662951733334137	18.086363636363636	-24.33571316400054	IL1B;TNF
KEGG_2021_Human	Alzheimer disease	3/369	0.008924054845697141	0.01809600010377476	9.018735362997658	-18.187178129854335	IL1A;IL1B;TNF
KEGG_2021_Human	Measles	2/139	0.012084353093672291	0.023842102049677762	14.472627737226277	-19.639406588988233	IL1A;IL1B
KEGG_2021_Human	Pathways of neurodegeneration	3/475	0.017772166326566263	0.03414126689050887	6.897094430992736	-13.07371705691191	IL1A;IL1B;TNF
KEGG_2021_Human	Terpenoid backbone biosynthesis	1/22	0.026917919418171	0.05038482352632007	42.576719576719576	-21.34946103825324	MVK
KEGG_2021_Human	Human cytomegalovirus infection	2/225	0.029995320515188703	0.05474145994021939	8.794843049327355	-11.607417281005194	IL1B;TNF
KEGG_2021_Human	Asthma	1/31	0.03774052193970927	0.0671965390633848	29.77037037037037	-16.126223630092912	TNF
KEGG_2021_Human	Allograft rejection	1/38	0.046083072411820386	0.08009676871578306	24.117117117117118	-13.560364723090352	TNF
KEGG_2021_Human	Type II diabetes mellitus	1/46	0.05553766478796506	0.0942848727795686	19.809876543209878	-11.46289716991079	TNF
KEGG_2021_Human	Amyotrophic lateral sclerosis	2/364	0.07172754804182349	0.1190025228875708	5.321823204419889	-6.226988268408014	CASP1;TNF
KEGG_2021_Human	Adipocytokine signaling pathway	1/69	0.08225170002715665	0.12953243675800227	13.071895424836601	-7.854937277937848	TNF
KEGG_2021_Human	RIG-I-like receptor signaling pathway	1/70	0.08339759626885078	0.12953243675800227	12.880837359098228	-7.74542097629872	TNF
KEGG_2021_Human	Fc epsilon RI signaling pathway	1/68	0.0811045146521906	0.12953243675800227	13.26865671641791	-7.96724592924887	TNF
KEGG_2021_Human	Antigen processing and presentation	1/78	0.09251851170984433	0.1407052365587216	11.531024531024531	-6.958150954500108	TNF
KEGG_2021_Human	Peroxisome	1/82	0.09704826642438931	0.14458211120368203	10.956104252400548	-6.615247747466243	MVK
KEGG_2021_Human	Hypertrophic cardiomyopathy	1/90	0.10604677818396174	0.15482829614858415	9.961298377028713	-6.010407578745034	TNF
KEGG_2021_Human	TGF-beta signaling pathway	1/94	0.11051569770952978	0.15818913593717007	9.528076463560334	-5.7422174156532195	TNF
KEGG_2021_Human	Dilated cardiomyopathy	1/96	0.11274260878642009	0.15827327771939745	9.32514619883041	-5.615549699272252	TNF
KEGG_2021_Human	Inflammatory mediator regulation of TRP channels	1/98	0.11496450084552494	0.1583473313532702	9.130584192439862	-5.49346810373269	IL1B
KEGG_2021_Human	Viral protein interaction with cytokine and cytokine receptor	1/100	0.11718138394436346	0.1584118708877506	8.94388327721661	-5.375723879218761	TNF
KEGG_2021_Human	T cell receptor signaling pathway	1/104	0.12160016340314761	0.1585849825992244	8.592233009708737	-5.152341092635986	TNF
KEGG_2021_Human	Th17 cell differentiation	1/107	0.1249011740201087	0.1585849825992244	8.345911949685535	-4.994589105830365	IL1B
KEGG_2021_Human	Insulin resistance	1/108	0.12599902727061665	0.1585849825992244	8.2668743509865	-4.943743954376122	TNF
KEGG_2021_Human	Herpes simplex virus 1 infection	2/498	0.12295964829332588	0.1585849825992244	3.816532258064516	-3.814605004177811	IL1B;TNF
KEGG_2021_Human	Toxoplasmosis	1/112	0.13037805537365837	0.1613152210555434	7.964964964964965	-4.748494648054986	TNF
KEGG_2021_Human	Sphingolipid signaling pathway	1/119	0.13799386385009413	0.16789253435094786	7.4858757062146895	-4.435243302362896	TNF
KEGG_2021_Human	Natural killer cell mediated cytotoxicity	1/131	0.1509099928727911	0.18059720458547132	6.7846153846153845	-3.968927686510734	TNF
KEGG_2021_Human	Systemic lupus erythematosus	1/135	0.15517650047822218	0.1827078150791971	6.5787728026534	-3.830244937455702	TNF
KEGG_2021_Human	Apoptosis	1/142	0.16259648475288416	0.1884054505866753	6.2466509062253746	-3.6047270952512624	TNF
KEGG_2021_Human	mTOR signaling pathway	1/154	0.17518011116339122	0.19720983817938	5.74800290486565	-3.2620286219941206	TNF
KEGG_2021_Human	Cellular senescence	1/156	0.17726075583432344	0.19720983817938	5.672401433691756	-3.209640069203435	IL1A
KEGG_2021_Human	Hepatitis C	1/157	0.17829930575122027	0.19720983817938	5.635327635327635	-3.183908163692195	TNF
KEGG_2021_Human	Hepatitis B	1/162	0.18347437883820783	0.19990492022670406	5.456866804692892	-3.0596637281364782	TNF
KEGG_2021_Human	Neutrophil extracellular trap formation	1/189	0.21091631211370437	0.22642486447500618	4.657210401891253	-2.4954112144854435	CASP1
KEGG_2021_Human	Epstein-Barr virus infection	1/202	0.22383065271253133	0.23650303816882798	4.3488114980652295	-2.274707784911856	TNF
KEGG_2021_Human	Proteoglycans in cancer	1/205	0.22678373523038298	0.23650303816882798	4.283224400871459	-2.2275706216550177	TNF
KEGG_2021_Human	Human immunodeficiency virus 1 infection	1/212	0.23363497492364255	0.24021624182290008	4.137440758293839	-2.12256354972075	TNF
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	1/219	0.24043153000367978	0.24377085680928645	4.001019367991845	-2.0240281738454993	TNF
KEGG_2021_Human	Human papillomavirus infection	1/331	0.3420488957114324	0.3420488957114324	2.6053872053872054	-1.0106876845884132	TNF
